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Letters to the Editorcolleagues.2 In that report, we hypothe-
sized that, among others, inappropriate
direct manipulation of the ePTFE by
surgical instruments could be a
causative factor. Subsequently, other
groups3-6 have reported such
occurrences, which have become less
rare. This has occurred proportionally
to the worldwide expanding use of
ePTFE for mitral valve reconstruction
in the form of neochordae to replace
ruptured or elongated native chordae
or to reinforce areas of leaflet prolapse
as an alternative to resection
techniques. The isolated reports have
rendered it difficult to understand the
genesis of this event, and we are
awaiting additional analysis of the
ultrastructure of the damaged material
to shed some light on the subject.
In our initial experience, we had
used size 4-0 Gore-Tex sutures but
subsequently reverted our practice
to using 5-0 because of the
presumed greater flexibility and
smaller volume of the multiple knots
required to fix the suture to the
leaflets. Other surgeons have also
used 5-0, although some have
continued to use 4-0.
We had, until now, assumed that the
well-known strength of ePTFE was a
guaranty of integrity and have used it
liberally, for more than 20 years, in
several hundreds of cases. Recently,
however, we encountered a couple of
other cases of ruptured artificial
chordae and started to interrogate
ourselves about the correctness of
this assumption. In contrast to our first
thoughts, we have increasing concern
that the 5-0 suture might not be strong
enough to withstand the systolic
tension of the closing mitral valve
leaflets. Hence, we have chosen to
return to using the 4-0 size and wish
to draw the attention of other surgeons
to this potential problem.
Although published data have
demonstrated that even after 10 years
ePTFE chordae are still flexible and
pliable, making them indistinguishable
fromnative chordae,7 evidence has also
shown that with the progression ofThe Journaltime, artificial chordae can degenerate,
calcify, and, eventually, rupture.
Early and late rupture has now been
reported with both sizes of ePTFE
suture; hence, other factors could
be involved; however, a little more
strength certainly will do no harm.
Manuel J. Antunes, PhD
Gonc¸alo F. Coutinho, MD
Centre of Cardiothoracic Surgery
University Hospital and Medical
School
Coimbra, PortugalReferences
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To the Editor:
We read with keen interest the
article by Gunn and colleagues1
regarding their opinion on extension
of sympathectomy for the treatment
of primary hyperhidrosis and occur-
rence of compensatory hyperhidrosisof Thoracic and Cardiovascular Surger(CH). Their retrospective review of
an unrandomized series of patients
suggested that severe CH was rare
and occurred irrespective of the level
or extension of sympathectomy.
From a methodologic point of view,
retrospective studies are, undoubtedly,
inferior to prospective assessments,
and randomized prospective trials are
significantly superior to the former.
There have been prospective and
randomized studies relating greater
frequency and discomfort of CH
after more proximal and extended
sympathectomy.2-4 In these studies,
different patients were randomly
assigned to undergo bilateral
symmetric sympathectomies (eg, a
patient was randomly assigned to
undergo bilateral T4 sympathectomy,
and another patient was randomly
assigned to undergo bilateral
T3-T4 sympathectomy). For palmar
and axillary hyperhidrosis, CH was
reported with lower frequency in
less extensive and less proximal
sympathectomies.
A study by Katara and coworkers5
had a different design, in which all
patients underwent operation on one
side with an extensive sympathectomy
(T2-T3) and on the other with a more
limited sympathectomy (T2). The side
of extensive sympathectomy was
randomly determined (left vs right),
but all patients had an extensive
sympathectomy on one side and a
limited sympathectomy on the other.
Their results showed, at best, that after
an extensive sympathectomy on one
side, most patients would have CH
bilaterally despite a less extensive
(T2 only) sympathectomy on the other
side.
We believe that extreme caution
must be taken if one considers, from
a single institutional and retrospective
review, that extended sympathectomy
does not influence the outcome of CH,
when prospective and randomized
studies have suggested otherwise.
CH, when present, may become a
difficult situation to deal with, and
extreme caution must be taken toy c Volume 148, Number 5 2443
Letters to the Editoravoid this undesirable outcome after
sympathectomy.
We are indeed concerned with
a strong recommendation of a
‘‘complete and adequate resection
for relief of symptoms,’’ and we
believe that attention must be brought
to this subject.
Marcelo Passos Teivelis, MD
Andrea Yasbek Varella, MD
Nelson Wolosker, MD, PhD
Hospital Israelita Albert Einstein
S~ao Paulo, BrazilReferences
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regarding the extent of sympathetic
chain removal and resulting com-
pensatory hyperhidrosis (CH) after
endoscopic thoracic sympathectomy
(ETS).1 There is little disagreement
that adequately powered randomized
prospective trials are superior to
nonrandomized prospective studies2444 The Journal of Thoracic andor retrospective reviews. Despite a
large body of literature on the topic,
however, few investigations have
performed randomized, clinical trials.
Significant controversy remains
regarding the optimal level and
extent of sympathetic chain removal
in the treatment of primary hyper-
hidrosis of the hands, axillae, feet,
and face.
The Society of Thoracic Surgeons
assembled an expert task force
to comprehensively review 102
studies, including 12 randomized
clinical trials, which determined that
the number of sympathetic levels
interrupted has been inconclusive as
a risk factor for moderate to severe
CH.2 These findings were consistent
with those previously published by
Kopelman and Hashmonai.3 In their
review of 87 studies, they statistically
determined that the literature did not
support claims that restricting the
extent of sympathetic ablation
resulted in a statistically significant
reduction in the frequency of CH.2
Even though we perform more
extensive resections (T2-T5 and
T2-T6) than commonly described in
the literature, our results are similar
or better than those in other studies.1
A recently published randomized
prospective trial by Cai and
colleagues4 containing 116 patients
with primary palmar hyperhidrosis
found that there were no significant
differences with respect to the
frequency of minor or severe CH in
patients who received either T2 to
T3 or more extensive T2 to T4 resec-
tions.4 A study by Leseche and col-
leagues,5 which compared T2 to T4
and T2 to T5 resections with more
limited ETS, also found that incidence
and severity of CH was not associated
with the extent of resection.
The physiologic basis of CH is still
not well understood, and the extent of
resection is only one of many factors
that likely influence the development
of severe CH. These include sex,
preoperative hyperhidrosis location
and degree,6 and possibly body massCardiovascular Surgery c November 20index, age, ethnicity, lifestyle, and
climate. Some consensus has been
reached regarding the recommended
location of interruption according to
the distribution of sweating, with T3
to T4 recommended for palmar sweat-
ing and T4 to T5 recommended for
both palmar, plantar and axillary
hyperhidrosis.2 Because many of our
patients had widespread symptoms,
including palmar, plantar, and axillary
sweating,we decided to tailor the oper-
ation on the basis their symptoms and
performed adequately extensive resec-
tions to improve patient satisfaction.1
Surgeons must balance the possibility
of persistent hyperhidrosis after inade-
quate resection against the risks of un-
necessarily excessive interruption that
could possibly lead to bradycardia,
Horner syndrome, or CH. At our insti-
tution, primarily extensive ETS was
performed between T2 to T5 and T2
to T6with positive patient satisfaction,
as well as some of the lowest rates of
CH reported in the literature.1 In light
of our experience and our review of
the literature, we therefore do not
recommend limiting the extent of
resection in an attempt to reduce the
incidence or severity of CH. Further
investigation is required, however, for
a better understanding of patient risk
factors for development of CH in addi-
tion to surgical technique and extent of
ETS.
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